Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMETHEP: Metabolic Profile of Hepatocarcinoma and Pancreatic Tumors
NCT05794048Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2022
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Trial (3 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Prognostic metabolic signatures of HCC at 24 months, Prognostic metabolic signatures of ADKP at 36 months and 4 more. Started Jun 2022; status: recruiting.
Beyond the preview
Go deeper on NCT05794048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05794048.